Navigation Links
Data Published in Proceedings of National Academy of Sciences Highlights Potential of Micromet's BiTE Antibody Platform
Date:6/29/2010

describe historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the potential of the Company's BiTE antibody technology and its use in the treatment of cancer. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that our preclinical data is not confirmed in clinical trials with our product candidates. This factor and others are more fully discussed in our Securities and Exchange Commission filings, including our Quarterly Report on Form 10-Q for the quarter ended March 31, 2010.  We caution you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made.  We disclaim any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014 /CNW/ - The Canadian Epilepsy Alliance (CEA) ... series designed to educate children about the most common neurological ... Medikidz Explain Epilepsy comic series tells a fictional story ... middle school while living with epilepsy. "Despite ... is still so much misinformation and lack of awareness out ...
(Date:8/21/2014)... , Aug. 21, 2014  Seventy-one percent of Americans believe ... is a serious public health and safety issue in ... a survey released today by Repass & Partners, a ... "Americans understand the severity of the prescription medication abuse ... with this very serious health situation facing our country," ...
(Date:8/21/2014)... , Aug. 21, 2014 InfinityQS International, ... Manufacturing Intelligence , today announces Infusion Chicago, ... event will be held Oct. 9-10, 2014, at ... designed to showcase the necessity for implementing a ... and Manufacturing Intelligence to gain insight into production ...
Breaking Medicine Technology:Action Heroes Harness Powers to Educate Children About Epilepsy 2Action Heroes Harness Powers to Educate Children About Epilepsy 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2
(Date:8/22/2014)... 2014 Until now, those with leg or ... walkers to keep mobile. Thanks to an inventor from Suffolk, ... effective. , He developed a prototype for the patent-pending SUPPORT ... or foot but provide comfort and reduce pain for those ... it is also convenient and easy to install on the ...
(Date:8/22/2014)... 265,000 Danes are acutely admitted to medical departments with ... and Aarhus University Hospital now shows that many of ... are sent home again without receiving a diagnosis of ... "Naturally, there is no need for a diagnosis if ... a serious illness. So some patients will always be ...
(Date:8/22/2014)... intolerance. However, these are two entirely different mechanisms that ... not digest lactose properly because they lack an enzyme ... much more dangerous cow milk allergy, however, the body,s ... antibodies. , According to statistics, about two to three ... milk allergy. Less adults are diagnosed with the disease. ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The ALS ... the ALS Center at Allegheny Health Network ... Center, based at Allegheny General Hospital (AGH), is the ... the ALS Association for meeting the highest levels of ... amyotrophic lateral sclerosis (ALS), often referred to as Lou ...
(Date:8/22/2014)... 21, 2014 (HealthDay News) -- The air in American ... Protection Agency reported Thursday. Significant progress has been ... air in recent decades, the agency said in a ... nearly 60 percent reduction in mercury from human sources ... benzene, and an 84 percent fall in lead, which ...
Breaking Medicine News(10 mins):Health News:Assistive Device for Walking Invented by InventHelp Client (VBL-501) 2Health News:Many patients are discharged without a diagnosis 2Health News:Scientists uncover why major cow milk allergen is actually allergenic 2Health News:Allegheny Health Network ALS Program Named Certified Treatment Center of Excellence 2Health News:Allegheny Health Network ALS Program Named Certified Treatment Center of Excellence 3Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2
... Sept. 14 The following is a,Statement by Oscar S. Wyatt, Jr.: "I,ve seen some ... politicians who want to,return those funds received from me, please return them in the form of ... ... Medical Foundation ...
... Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) management will be ... 43rd Annual Meeting of the European,Association for the Study ... a.m. PT / 1:30 p.m. CET local time in ... and recordings will be made,available following the event. The ...
... defects, U.S. experts say , , FRIDAY, Sept. 14 (HealthDay News) ... women since the federal government mandated folate fortification to prevent ... is enough -- or too much. , A new study ... finds that the number of women of childbearing age who ...
... Most people looking for tax advice,usually go to ... right? Here,s more on a new report that shows ... are actually not seeing the pros,trained in their field. ... Registered journalists can access video, audio, text, ...
... Blue Cross and Blue,Shield Association (BCBSA) convened a ... D.C., to discuss how insurers, doctors and hospitals,are ... safety.,Representatives from the Premier Inc. healthcare alliance, Duke ... Alabama, and WellPoint, Inc.,participated in the event. ...
... between the two protective treatments , FRIDAY, Sept. 14 (HealthDay ... a pill called dabigatran etexilate (DE) is just as effective ... blood clots after total hip replacement surgery. , As reported ... study included almost 3,500 hip replacement patients who received either ...
Cached Medicine News:Health News:Women's Folic Acid Levels Improving 2Health News:Women's Folic Acid Levels Improving 3Health News:Women's Folic Acid Levels Improving 4Health News:Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 2Health News:Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 3Health News:Blue Cross and Blue Shield Association Holds Forum to Explore Patient Safety and Healthcare Quality Initiatives 4Health News:Pill Equals Injection in Preventing Clots After Hip Replacement 2
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
... chairs with concave seats and large backrests ... seats, backrests, armrests, and casters and glides. ... performance in a variety of environments including: ... health care and office. • With tubular ...
Contoured waterfall-front ergonomic seats and generous backrests with lumbar support are standard on these ergonomic chairs. • With casters • With Tubular Base....
Medicine Products: